• Home

  • Documents

  • PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with...
7

PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest

Embed Size (px)

Citation preview

Page 1: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest
Page 2: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest
Page 3: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest
Page 4: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest
Page 5: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest
Page 6: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest
Page 7: PowerPoint Presentationwcm/@hcm/@sta… · ACUTE ISCHEMIC STROKE TREATMENT: Dissolve clot with tissue plasminogen activator a/tep/ase (IV rt-PA). The benefits of tPA therapy are greatest

Characterization of the Gene for Human Plasminogen

Characterization of the Gene for Human Plasminogen

Documents
Dissolve Oxygen

Dissolve Oxygen

Documents
Urokinase-type plasminogen clearance receptor or tissue

Urokinase-type plasminogen clearance receptor or tissue

Documents
PGM Guidelines for description of criteria and …complete as possible representing biologi-cal function, such as the clot lysis assay for plasminogen activators. This should mini-mize

PGM Guidelines for description of criteria and …complete as possible representing biologi-cal function, such as the clot lysis assay for plasminogen activators. This should mini-mize

Documents
Stop That Clot

Stop That Clot

Health & Medicine
Clot Felter Cook Lottery

Clot Felter Cook Lottery

Documents
Alveolar Epithelial Cell Plasminogen Activator · Alveolar Epithelial Cell Plasminogen Activator CHARACTERIZATION AND REGULATION* (Received for publication, November l&1989) Bruce

Alveolar Epithelial Cell Plasminogen Activator · Alveolar Epithelial Cell Plasminogen Activator CHARACTERIZATION AND REGULATION* (Received for publication, November l&1989) Bruce

Documents
Lipoprotein (a) Regulates Plasminogen Activator Inhibitor- 1

Lipoprotein (a) Regulates Plasminogen Activator Inhibitor- 1

Documents
 · inhibited in the free phase by plasminogen activator inhibitor type 1 (PAI- l). ... Adsorption/desorption rates are estimated from Kd in the ... a 1 cm-long clot, the

 · inhibited in the free phase by plasminogen activator inhibitor type 1 (PAI- l). ... Adsorption/desorption rates are estimated from Kd in the ... a 1 cm-long clot, the

Documents
Sub 1.3 - Blood Clot Mechanism

Sub 1.3 - Blood Clot Mechanism

Documents
Plasminogen activators: a morphologist's · Plasminogen activators: a morphologist's view Fig. 1 Fibrinolysis autograph ofnervefromlimb afterprolongedischaemia. Haloes indicate centres

Plasminogen activators: a morphologist's · Plasminogen activators: a morphologist's view Fig. 1 Fibrinolysis autograph ofnervefromlimb afterprolongedischaemia. Haloes indicate centres

Documents
Template of 2nd CLOT Report

Template of 2nd CLOT Report

Documents
Clot 17 marzo

Clot 17 marzo

Documents
CLOT 21 JULIOL

CLOT 21 JULIOL

Documents
Diagnosis / Lab Findings - NCAPA · 2017-02-15 · Things to make you go hmmmmm… Family history of clot Recurrent clot Repeated clot despite adequate anticoagulation Venous clot

Diagnosis / Lab Findings - NCAPA · 2017-02-15 · Things to make you go hmmmmm… Family history of clot Recurrent clot Repeated clot despite adequate anticoagulation Venous clot

Documents
CAUSES OF BLEEDING Defective clot formation Platelet plug Fibrin clot Excessive fibrinolysis Vascular fragility

CAUSES OF BLEEDING Defective clot formation Platelet plug Fibrin clot Excessive fibrinolysis Vascular fragility

Documents
Blood Clot Formation

Blood Clot Formation

Documents
Review Urokinase Plasminogen Activator Receptor (uPAR ... › v03p0507.pdfUrokinase Plasminogen Activator Receptor (uPAR) Targeted Nuclear Imaging and Radionuclide Therapy Dan Li1,

Review Urokinase Plasminogen Activator Receptor (uPAR ... › v03p0507.pdfUrokinase Plasminogen Activator Receptor (uPAR) Targeted Nuclear Imaging and Radionuclide Therapy Dan Li1,

Documents
Clot Acelobert

Clot Acelobert

Documents
Transactivation of the Urokinase-type Plasminogen Activator

Transactivation of the Urokinase-type Plasminogen Activator

Documents
El Clot Acelobert octubre

El Clot Acelobert octubre

Documents
asphaltene dissolve

asphaltene dissolve

Documents
Altered expression of urokinase-type plasminogen activator ......expression of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR) and plasminogen activator inhibitor-1

Altered expression of urokinase-type plasminogen activator ......expression of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR) and plasminogen activator inhibitor-1

Documents
Soluble Fibrin Degradation Products Potentiate Tissue Plasminogen

Soluble Fibrin Degradation Products Potentiate Tissue Plasminogen

Documents
Mechanical Clot Detection Stago’s Viscosity-based Clot Detection System

Mechanical Clot Detection Stago’s Viscosity-based Clot Detection System

Documents
Lecture 11 & 12 Clot

Lecture 11 & 12 Clot

Technology
Plot The Clot

Plot The Clot

Documents
Recombinant Tissue Plasminogen Activator Increases Blood

Recombinant Tissue Plasminogen Activator Increases Blood

Documents
EFFORTS - Emphysema · DVT by spreading the drug over a surface area of the clot. Thirty minutes later -- when the clot begins to partially dissolve-- the spray is used to create

EFFORTS - Emphysema · DVT by spreading the drug over a surface area of the clot. Thirty minutes later -- when the clot begins to partially dissolve-- the spray is used to create

Documents
Enhancement of fibrinolysis in vitro by · MHz ultrasound at intensities up to 8 W/cm2. Plasma clot lysis at 1 h with 1 microgram/ml recombinant tissue plasminogen activator (rt-PA)

Enhancement of fibrinolysis in vitro by · MHz ultrasound at intensities up to 8 W/cm2. Plasma clot lysis at 1 h with 1 microgram/ml recombinant tissue plasminogen activator (rt-PA)

Documents